Cargando…
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy
BACKGROUND: Diffuse pleural mesothelioma (DPM) is an aggressive therapy-resistant cancer with unique molecular features. Numerous agents have been tested, but clinically effective ones remain elusive. Herein, we propose to use a small molecule CBL0137 (curaxin) that simultaneously suppresses nuclear...
Autores principales: | Singh, Anand, Pruett, Nathanael, Dixit, Shivani, Gara, Sudheer K., Wang, Haitao, Pahwa, Roma, Schrump, David S., Hoang, Chuong D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652639/ https://www.ncbi.nlm.nih.gov/pubmed/37974213 http://dx.doi.org/10.1186/s13046-023-02889-6 |
Ejemplares similares
-
MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis
por: Singh, Anand, et al.
Publicado: (2021) -
Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma
por: Dixit, Shivani, et al.
Publicado: (2022) -
Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling()
por: Zhang, Li, et al.
Publicado: (2019) -
Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
por: Choi, Agnes Y., et al.
Publicado: (2022) -
Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)